🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study proposes to assess the effect of multiple applications of antimic...
Status
Completed
Location
Mariana Sales
Start Date
2014-09-01
Trial ID
NCT03039244
Treatments Being Tested
This open-label Phase I study is designed to determine the maximum tolerate...
Status
Completed
Location
Weill Cornell Medical College
Start Date
2009-06-02
Trial ID
NCT00875693
Treatments Being Tested
Dyslipidemia is an independent risk factor for cardiovascular events. Stati...
Status
Unknown
Location
the first affiliated hospital of Harbin medical university
Start Date
2019-09-01
Trial ID
NCT03610321
Background Diabetes mellitus (DM) is a significant contributor to adverse o...
Status
Completed
Location
Cairo University
Start Date
2022-07-29
Trial ID
NCT05479214
Study to determine the best dose of stereotactic body radiation therapy (SB...
Status
Completed
Location
University of Chicago Medical Center
Start Date
2018-03-15
Trial ID
NCT03431948
Treatments Being Tested
The purpose of the Phase 1 part of the study is to determine the maximum to...
Status
Terminated
Location
California Cancer Associates For Research and Exellence, cCare
Start Date
2014-07-30
Trial ID
NCT01999335
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
Algemeen Ziekenhuis Middelheim
Start Date
1993-03
Trial ID
NCT00002517
Radiotherapy can activate local and systemic immune responses through a var...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-04
Trial ID
NCT06914050
Treatments Being Tested
The GI-4000 therapeutic vaccine or placebo will be injected under the skin ...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2006-01
Trial ID
NCT00300950
Treatments Being Tested
According to literature reports, about 16.3%-19% of newly diagnosed NSCLC p...
Status
Unknown
Location
Chongqing University Cancer Hospital
Start Date
2021-03-01
Trial ID
NCT04905550